Bio-Rad Laboratories Inc.

S&P 500

BIO/Healthcare · Medical Devices/NYSE

Stock Price

$298.29

Stock Price$298.29P/E46.7MCap7.5BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

Dividend Safety Rating

BIO does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and markets specialized products for the clinical diagnostics and life sciences markets. In clinical diagnostics, the company provides test systems and quality control solutions for clinical laboratories. In life sciences, it produces instruments and reagents for research, biopharmaceutical production, and food testing, with a leadership position in digital PCR technology. The company operates globally across the Americas, Europe, and Asia, serving pharmaceutical companies, research institutions, clinical laboratories, and bioprocessing manufacturers. Bio-Rad also maintains a significant ownership stake in Sartorius, a supplier specializing in single-use bioprocessing technology. Founded in 1952 and headquartered in Hercules, California, the company operates a razor-and-blade business model in clinical diagnostics, combining durable instruments with recurring sales of consumable products and reagents to maintain steady revenue streams.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$235.01 - $343.12

Earnings & Profitability

BIO earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

—

Next Payment Date

—

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

BIO Dividend Calculator

Number of Shares

Total Investment

$29,829.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is BIO's current dividend yield?

Bio-Rad Laboratories Inc. (BIO) currently has a dividend yield of 0.00%, based on a stock price of $298.29 and an annual dividend of $0.00.

When is BIO's next dividend payment date?

BIO's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does BIO pay in dividends per year?

Bio-Rad Laboratories Inc. pays dividends unknown. Annual dividend data is not yet available.

Has BIO been increasing its dividend?

Bio-Rad Laboratories Inc. has grown its dividend at a 5-year CAGR of —.

Is BIO's dividend safe?

Bio-Rad Laboratories Inc. has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.

How is BIO's Dividend Safety Rating calculated?

The Dividend Safety Rating evaluates Bio-Rad Laboratories Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track BIO Dividends with OnlyDividends

What will BIO actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.